U.S. Construction Stock News

NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

3 AI Infrastructure Stocks With Strong Earnings Growth On Healthy Balance Sheets

Cooling US inflation expectations and wage growth have shifted attention back to companies that can grow earnings even if interest rate paths stay uncertain. That is where the Healthy high growth potential screener earns a closer look. It focuses on stocks where analysts see strong earnings growth and balance sheets that pass basic health checks. This article highlights 3 standouts that fit that profile today. The 3 stocks below are just a starting sample. The full screen surfaced another 272...
NYSE:BWA
NYSE:BWAAuto Components

Why Is BorgWarner (BWA) Expanding Its Edge In China And EV Systems?

BorgWarner (NYSE:BWA) announced multiple new contracts for variable cam timing systems in Europe and China, including a conquest award from a China based automaker. The company reported that these variable cam timing wins expand its position with existing customers and replace a competitor on a China program. BorgWarner also secured new awards for high voltage inverters and integrated drive modules for hybrid and electric vehicle platforms. The company described these contracts as material...
NasdaqGS:FTAI
NasdaqGS:FTAIAerospace & Defense

Where Does FTAI Aviation (FTAI) Valuation Sit On Earnings And Dividend News?

FTAI Aviation (FTAI) shares have been reacting to the company’s July 29 earnings release and dividend declarations, which gave investors fresh data on revenue, profit and cash returns in the latest quarter. See our latest analysis for FTAI Aviation. The latest earnings and dividend announcements have been the main catalysts for FTAI Aviation’s recent trading, with the stock easing 2.3% on a 1-day share price return while still showing a 4.97% 7-day share price gain and a very large 5-year...
NasdaqGS:ORIC
NasdaqGS:ORICBiotechs

ORIC Pharmaceuticals (ORIC) Q2 Losses Put Valuation In Focus As Shares Rally

Why ORIC Pharmaceuticals Stock Is Back in Focus After Q2 Earnings ORIC Pharmaceuticals (ORIC) has drawn fresh attention after reporting second quarter and first half 2026 results, with a wider net loss but an improved basic loss per share from continuing operations. See our latest analysis for ORIC Pharmaceuticals. The earnings update and recent shelf registration have come alongside strong share price momentum. ORIC Pharmaceuticals has posted a 7 day share price return of 21.95% and a 90 day...
NYSE:BROS
NYSE:BROSHospitality

Dutch Bros (BROS) Lifts 2026 Outlook and Buys Drive-Thrus Is Its Expansion Strategy Evolving?

Dutch Bros Inc. reported past second-quarter 2026 results with revenue of US$550.85 million and net income of US$37.41 million, alongside higher full-year revenue guidance of US$2.10–US$2.13 billion. The company also agreed to acquire up to 65 former Salad and Go drive-thru sites for US$105 million, aiming to convert them into Dutch Bros locations and accelerate its footprint expansion across Arizona, Nevada, Oklahoma, and Texas in 2027. We’ll now examine how Dutch Bros’ raised revenue...
NYSE:WU
NYSE:WUDiversified Financial

Can Western Union (WU) Stay Cheap As Profit Pressures Persist?

Western Union stock has delivered a sharp 52.8% decline over the past 5 years, yet its current valuation checks still suggest the shares lean cheap relative to fundamentals. This makes the recent price level a key focus for investors trying to judge whether that pessimism has already been fully reflected. The 52.8% share price decline over 5 years points to a market that has marked Western Union down heavily and raises the question of whether expectations have been reset too...
NasdaqGS:CLBT
NasdaqGS:CLBTSoftware

Is Cellebrite (CLBT) Using Drone Forensics To Deepen Its AI Cloud Investigation Moat?

Cellebrite DI recently expanded its exclusive partnership with SkySafe to strengthen drone detection and airspace intelligence tools used in digital investigations, and the company is set to release its second-quarter 2026 results on August 13, 2026. This combination of product expansion into drone-related forensics and an imminent earnings update highlights how Cellebrite is positioning its platform for emerging investigative needs. We'll now examine how the expanded SkySafe partnership...
NasdaqGS:TDUP
NasdaqGS:TDUPSpecialty Retail

Is ThredUp’s (TDUP) Revenue Guidance Enough To Reframe Its Loss-Making Resale Platform Narrative?

In August 2026, ThredUp Inc. reported second-quarter 2026 results showing sales of US$90.77 million versus US$77.66 million a year earlier, alongside a wider net loss of US$5.94 million and basic loss per share of US$0.05. The company also issued new revenue guidance for the third and fourth quarters and full year 2026, outlining expected mid‑single‑digit to low‑double‑digit year-over-year growth, which gives investors clearer visibility into its near-term scale ambitions despite ongoing...